http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2376664-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-097
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
filingDate 1978-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1978-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2376664-A1
titleOfInvention L-PROLINAMIDE DERIVATIVE AND ITS USE AS A THERAPEUTIC MEDIUM FOR THE TREATMENT OF EYE DISEASES
abstract Therapeutic means for the treatment of eye diseases. Eye diseases in mammals, such as progressive cataract or conjunctivitis, are effectively treated by administering to the mammal a hormone releasing thyroid stimulating hormone. The effect of the treatment is increased by administering said hormone at the same time with an adrenocortical hormone. Use of this eye drops for rapid treatment of cataracts and inflammatory eye diseases.
priorityDate 1977-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3932623-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2262997-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4059692-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID111306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457533579

Total number of triples: 24.